[Acrodermatitis enteropathica in the light of occurrence analysis].
D000169:Acrodermatitis / Q000453:epidemiology*; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005730:Ganglionic Blockers / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000453:epidemiology*; D006219:Halogens / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007421:Intestine, Small / Q000378:metabolism; D008875:Middle Aged; D008895:Milk, Human; D011804:Quinolines / Q000627:therapeutic use; D012737:Sex Factors; D014364:Tryptophan / Q000378:metabolism
D005730:Ganglionic Blockers; D006219:Halogens; D011804:Quinolines; D014364:Tryptophan
Die Acrodermatitis enteropathica im Lichte der Häufigkeitsanalyse.